Congressional Trader
Live

CTSH congressional trades

7 matched disclosures

Track congressional trades for CTSH
Tracked disclosures
7
Lawmakers
5
Buy / sell
3 / 4
Avg post-trade move
N/A
Latest filing 2026-04-07

CTSH congressional trades snapshot

This page summarizes public STOCK Act disclosures involving CTSH. It is useful for seeing which lawmakers reported CTSH transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Apr 7, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the CTSH congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for CTSHacross 5 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent CTSH filing shown here was filed on Apr 7, 2026 by Gilbert Ray Cisneros as a purchase. Related lawmakers include John James, Lisa C. McClain, Gilbert Ray Cisneros, Josh Gottheimer, Kevin Hern.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
No committee data
Filed Apr 7, 2026
Delay 25 days
View filing
Cognizant Technology Solutions
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Kevin HernR-OKHouse
No committee data
Filed Apr 3, 2026
Delay 17 days
View filing
Cognizant Technology Solutions Corporation - Class A Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 28 days
View filing
Cognizant Technology Solutions
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 34 days
View filing
Cognizant Technology Solutions Corporation - Class A Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John JamesR-MIHouse
No committee data
Filed Sep 6, 2024
Delay 2 days
View filing
Cognizant Technology Solutions
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John JamesR-MIHouse
No committee data
Filed Sep 2, 2024
Delay 297 days
View filing
CTSHNotable
Cognizant Technology Solutions Corporation - Class A Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 15, 2024
Delay 16 days
View filing
Cognizant Technology Solutions
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded CTSH?

Recent CTSH disclosures include John James, Lisa C. McClain, Gilbert Ray Cisneros, Josh Gottheimer, Kevin Hern.

What is the buy/sell mix for CTSH?

The visible sample currently shows 3 purchases and 4 sales or partial sales.

Should I trade based on CTSH disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.